Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy.
Mizuhara K, Fujii N, Meguri Y, Takahashi T, Aoe M, Nakamura M, Seike K, Sando Y, Fujii K, Abe M, Sumii Y, Urata T, Fujiwara Y, Saeki K, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Maeda Y.
Mizuhara K, et al. Among authors: fujii n, fujii k.
Int J Hematol. 2020 Sep;112(3):422-426. doi: 10.1007/s12185-020-02886-x. Epub 2020 Apr 27.
Int J Hematol. 2020.
PMID: 32342335